Barr Settles Mirapex, Aggrenox Patent Suits
A unit of generics maker Barr Pharmaceuticals Inc. struck deals with Boehringer Ingelheim that should resolve patent suits over the stroke prevention treatment Aggrenox and the restless leg syndrome drug Mirapex,...To view the full article, register now.
Already a subscriber? Click here to view full article